We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

186 hedge funds and large institutions have $553M invested in Aurinia Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more capital invested

Capital invested by funds: $223M → $553M (+$330M)

50% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 46

40% more call options, than puts

Call options by funds: $30.4M | Put options by funds: $21.7M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.88% less ownership

Funds ownership: 36.31% → 35.43% (-0.88%)

3% less funds holding

Funds holding: 192 → 186 (-6)

10% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 30

Holders
186
Holders Change
-6
Holders Change %
-3.13%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
69
Reduced
46
Closed
30
Calls
$30.4M
Puts
$21.7M
Net Calls
+$8.65M
Net Calls Change
+$2.62M

Top Buyers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$7.51M
2
Goldman Sachs
Goldman Sachs
New York
+$4.57M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.51M
4
Morgan Stanley
Morgan Stanley
New York
+$3.4M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.31M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$11.7M
2
AC
Armistice Capital
New York
-$7.29M
3
BG
Bellevue Group
Switzerland
-$5.57M
4
Bank of America
Bank of America
North Carolina
-$2.69M
5
AA
AlphaCentric Advisors
Puerto Rico
-$2.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$4.02M +$2.05M +232,868 +174%
Stifel Financial
27
Stifel Financial
Missouri
$3.86M +$242K +27,463 +8%
Group One Trading
28
Group One Trading
Illinois
$3.54M +$59.3K +6,736 +2%
Charles Schwab
29
Charles Schwab
California
$3.35M +$46.4K +5,269 +2%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$3.16M +$1.84M +209,100 +264%
CSS
31
Cubist Systematic Strategies
Connecticut
$2.97M +$1.26M +143,375 +112%
Simplex Trading
32
Simplex Trading
Illinois
$2.87M +$896K +101,670 +64%
Swiss National Bank
33
Swiss National Bank
Switzerland
$2.86M -$269K -30,500 -10%
LFAS
34
Level Four Advisory Services
Texas
$2.74M +$2.11M +239,000 +2,134%
Hudson Bay Capital Management
35
Hudson Bay Capital Management
Connecticut
$2.65M -$1.23M -140,000 -37%
JP Morgan Chase
36
JP Morgan Chase
New York
$2.32M +$625K +70,932 +50%
JFG
37
Jefferies Financial Group
New York
$2.19M +$1.76M +200,000 New
ASN
38
Advisory Services Network
Georgia
$2.15M +$392K +44,508 +29%
TI
39
Trexquant Investment
Connecticut
$2.03M +$772K +87,618 +90%
Wells Fargo
40
Wells Fargo
California
$1.98M +$245K +27,855 +18%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.9M +$61.2K +6,949 +4%
HWAM
42
Hennion & Walsh Asset Management
New Jersey
$1.75M -$46.7K -5,302 -3%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.71M -$19.6K -2,229 -1%
UBS AM
44
UBS AM
Illinois
$1.63M +$55.3K +6,277 +4%
Parallax Volatility Advisers
45
Parallax Volatility Advisers
California
$1.56M -$949K -107,730 -43%
AllianceBernstein
46
AllianceBernstein
Tennessee
$1.49M – – –
UBS Group
47
UBS Group
Switzerland
$1.44M +$748K +84,912 +182%
Walleye Trading
48
Walleye Trading
New York
$1.41M +$1.14M +129,080 New
Invesco
49
Invesco
Georgia
$1.39M +$389K +44,128 +53%
CS
50
Credit Suisse
Switzerland
$1.37M +$75.6K +8,580 +7%
1
2
3 4 5

AUPH Hedge Fund Activity: Q1 2023 in Review

186 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q1 2023, worth a combined $553M — up 148% from $223M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AUPH and 27 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 69 added.

The largest buyer was Balyasny Asset Management, adding an estimated $7.51M. The largest seller was Citadel Advisors, cutting an estimated $11.7M.

  • 186 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q1 2023, down from 192 in Q4 2022.
  • Funds reported $553M of Aurinia Pharmaceuticals stock for Q1 2023, up 148% quarter-over-quarter.
  • 27 funds opened new Aurinia Pharmaceuticals positions in Q1 2023 and 30 closed out, a net change of -3 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q1 2023 was Balyasny Asset Management, an estimated $7.51M added.
  • The largest Aurinia Pharmaceuticals seller in Q1 2023 was Citadel Advisors, an estimated $11.7M sold.

Based on aggregated 13F filings for Q1 2023.